BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23251247)

  • 1. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma.
    Zhu J; Jiang F; Ni HB; Xiao MB; Chen BY; Ni WK; Lu CH; Ni RZ
    Exp Ther Med; 2013 Jan; 5(1):89-94. PubMed ID: 23251247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
    Zhang SY; Lin BD; Li BR
    FEBS Open Bio; 2015; 5():240-4. PubMed ID: 25870783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.
    Hou SC; Xiao MB; Ni RZ; Ni WK; Jiang F; Li XY; Lu CH; Chen BY
    Oncol Lett; 2013 Oct; 6(4):1152-1158. PubMed ID: 24137480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
    Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
    World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of serum gamma-glutamyl transferase isoenzyme for hepatocellular carcinoma: a 10-year study.
    Xu K; Meng XY; Wu JW; Shen B; Shi YC; Wei Q
    Am J Gastroenterol; 1992 Aug; 87(8):991-5. PubMed ID: 1353662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum AFU, 5'-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis.
    Junna Z; Gongde C; Jinying X; Xiu Z
    Open Med (Wars); 2017; 12():354-358. PubMed ID: 29043300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
    Wang JJ; Cao EH
    Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
    Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
    Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
    Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
    Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer].
    Shi X; Zhou Y; Xia L
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):437-9. PubMed ID: 10920938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates.
    Ekmen N; Akalin Ç; Akyildiz M
    Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):294-299. PubMed ID: 32796360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Combined Serum Marker Tests in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Xie L; Luo X
    Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37917888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of an enzyme-linked immunosorbent assay detecting hepatoma-specific gamma-glutamyltransferase.
    Wang NY; Zhang D; Zhao W; Fang GX; Shi YL; Duan MH
    Hepatol Res; 2009 Oct; 39(10):979-87. PubMed ID: 19624768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
    Gan Y; Liang Q; Song X
    Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological biomarkers of hepatocellular carcinoma in Egyptian patients.
    El-Tayeh SF; Hussein TD; El-Houseini ME; Amer MA; El-Sherbini M; Elshemey WM
    Dis Markers; 2012; 32(4):255-63. PubMed ID: 22430192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
    Shen W; Shen DM
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
    Hussein TD
    Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of diagnostic significance of a hepatoma-specific band of serum gamma-glutamyl transferase.
    Xu KC; Shi YC; Meng XY; Wei Q
    Chin Med J (Engl); 1990 Mar; 103(3):228-32. PubMed ID: 1973381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.